A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

14806GSK-219606-AZUR-2Open (affiliates only) A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer219606NCT05855200IndustrialAdultTreatmentIIIGlobalColonTesfaye, AntenehMedstar Washington Hospital Center : Shelley CollinsGastrointestinalOncology GroupMHRI Washington Cancer Institute13603Shelley CollinsShelley CollinsShelley.R.Collins@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>